Session 1: Sustainability in Health Care
The Despite the economic slump and limited health care resources, health care needs and medical costs continue to rise. Methods allowing a balance to be struck between health care cost suppression and health care quality improvement initiatives will become an issue in the near future. Is it possible for innovation and sustainability to coexist amidst the everlasting invention of ground breaking new drugs and new health care technologies. As a first step into the topic of financial affairs, discussions were held focusing on ways to improve sustainability in health care.

Panelists
Hirotaka Unami
(Senior Director for Social Security Budget, Ministry of Finance)

Mariko Oyamada
(HGPI Senior Manager)

Session 2: Global Health – G7 Summit and beyond
In 2016, Japan is playing host to the G7 Summit and Health Ministers’ Meeting, giving Japan the opportunity to strengthen its role as a global health leader and significantly contribute to the improvement of health around the world. The meaning of global health, which up until now has been focused on development assistance, is currently changing. This session focused on the contributions Japan is expected to make and the benefits of these contributions to Japan’s future. Panelists and participants discussed human resource development and the disaster management frameworks required at a global level.

Moderator
Anne Smith
(Manager, Health and Global Policy Institute)

Session 3: The Future of Health Care

Due to the size of the challenges faced and the height of the hurdles that need to be overcome, discussions about health care policy tend to stop at merely pointing out that issues exist. The original purpose of health care was to bring about “bright, future-oriented stories” by ensuring health for the people and the creation of a strong foundation for society. This session saw deep discussions surrounding emerging resources and innovative ideas aimed at supporting health policy makers and stakeholders in the construction of a stronger and more optimistic health care system.

Panelists
Seigo Izumo
(Senior Vice President, Global Head of Regenerative Medicine Unit and Head of Scientific Affairs in Japan at Takeda Pharmaceutical Company)

Tomiko Tawaragi
(Chief Safety Officer, Pharmaceuticals and Medical Devices Agency (PMDA))

Shinsuke Muto
(President of Tetsuyu Institute Medical Corporation, Japan; Executive Advisor for Information Policy, MHLW; Co-Founder & Medical Director (Admin), Tetsuyu Healthcare Holdings, Japan)

Moderator
Ryoji Noritake
(Fellow, Health and Global Policy Institute; Consultant, Project HOPE (U.S. based NGO)

Comments and questions from participants

Exhibition date：2016-02-27